Diagnosis and treatment of pneumonia in children
DOI:
https://doi.org/10.62480/tjms.2023.vol19.pp52-57Keywords:
community-acquired pneumonia, bacterial, viral, antibacterial drugsAbstract
Early diagnosis and rational therapy pneumonia in children is an urgent task of pediatrics. For diagnosing a bacterial infection, especially a severe one, assessing the appearance and behavior of the child is much more important than reading a thermometer [6,7]. Signs that allow to assess the severity of intoxication, common with a bacterial infection, include a rapid disturbance violation of the general condition, a decrease in the activity of the child; irritability (screaming when touched), lethargy, drowsiness (sleep longer), lack of eye contact of the child during examination, the child refuses to eat and drink. The severity of the condition is determined by the severity of tachycardia, muffled heart sounds, hypo- or hyperventilation, cough, dyspnea, bronchophony and local rales, violation of microcirculation, peripheral cyanosis, incessant vomiting. Amoxicillin is effective against most of the pathogens that cause communityacquired pneumonia. Patients in the presence of underlying diseases or taking antibiotics in the previous 3 months are prescribed amoxicillin / clavulanate in monotherapy or in combination with macrolides (azithromycin, clarithromycin). Macrolides should also be used when mycoplasma or chlamydial pneumonia is suspected
References
Community-acquired pneumonia in children: prevalence, diagnosis, treatment and prevention // Scien.-pract. program. - M.: Original maket, 2011. - 64 p.
Clinical pharmacology: national guidelines / Ed. Yu. B. Belousova, V. G. Kukesa, V. K. Lepakhina and others. - M .: GEOTAR-Media, 2009. - 976 p.
Order of the Ministry of Health of the Russian Federation dated December 29, 2012 No. 1658n “On approval of the standard for specialized medical care for moderate pneumonia”.
Karimdjanov I.A., Fayzieva U.R. Genetic Predisposition To Out-Of-Hospital Pneumonia In Children: A Modern Interpretation Of The Problem. The American Journal of Medical Sciences and Pharmaceutical Research, 2021 3(05), 51-57
Geppe N.A., Rozinova N.N., Kozlova N.V. Rational antibacterial therapy for community-acquired pneumonia in children // Klin. urgent ped. - 2015. - V. 1, No. 1. - P. 24.
Bradley J.S., Byington C., Shah S.S. Alverson B. et.al. The management of community-aquired pneumonia in infants and children older than 3 month of age: clinical practice guidelinesby the Pediatric Infetious Deseases Society and the Infetious Deseases Society of America. Clin Infect Dis. 2011; 53(7):25-76. Doi: 10. 1093/cid/cir531
Gunaratnam LC, Robinson JL, Hawkes MT. Systematic Review and Meta-Analysis of Diagnostic Biomarkers for Pediatric Pneumonia. J Pediatric Infect Dis Soc 2021; 10:891.
Kuitunen I, Jääskeläinen J., Korppi M, Renko M. Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis. Clin Infect Dis. 2023;76(3):1123-1128.doi:10.1093/cid/ciac374
Korppi M. Antibiotic therapy in children with community-acquired pneumonia. Acta Paediatr 2021; 110:3246–50.
Williams DJ, Creech CB, Walter EB, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr 2022; 176:253–61.
Karimdzhanov I.A.,Gazieva A.S.,Togaev M.K. Community-Acquired Pneumonia in Children (Literature Review). Euroas J of med and nat scien, 2023, 3(1):34-41. doi:10.5281/zenodo.7512069
Williams DJ, Creech CB, Walter EB, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr 2022; 176:253–61.
Kurbanova M. R., Shamsiev F.M., Musajanova R.A. Modern approaches to the selection of protected cefalosporins III for therapy of community-acquired pneumonia in children. Europ. J of Molec and Clin Med. 2020; 7(3): 3008-3014
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
